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We have developed a urethral dosimetry system for real time dose verification along the urethra during
permanent implant prostate brachytherapy. The urethral alarm probe uses “spectroscopic dosimetry” to calculate the
dose rate along the urethra in real time. The application of spectroscopic dosimetry for the urethral alarm probe was
verified using Monte Carlo calculations. In phantom depth dose measurements as well as isotropy measurements
were performed to verify the usefulness of the urethra alarm probe as an in vivo real time dosimeter.
KEYWORDS: permanent implant, brachytherapy, prostate, real time, spectroscopic dosimetry, Monte Carlo

I. Introduction
Permanent prostate implants are a common treatment
modality for early stage prostate cancer. Reducing the risk of
complications, whilst at the same time maintaining good
dosimetric coverage of the tumor, is a major concern in
prostate brachytherapy. We have developed a probe which
measures in real time the dose delivered along the urethra
and may be used by the physicians during seed implantation
to monitor for excessive doses. In vivo dosimetry is
commonly performed with miniature radiation detectors
such as MOSFETs or diodes1). The main disadvantages of
such systems are energy dependence and low sensitivity. The
urethral alarm probe circumvents these problems by
measuring the energy spectrum of the treatment radiation
field. The dose rate at the point of measurement is
proportional to the magnitude of the measured photopeaks.
The urethral alarm probe consists of a silicon mini-detector
connected to a shaping amplifier and discriminator, located
inside a cable small enough to be inserted within a urethral
catheter. A portable data acquisition system provides real
time dose calculations and extrapolated total treatment doses.
The following reports on Monte Carlo calculations and
physical experiments to confirm the suitability of
spectroscopic dosimetry as a tool for low dose rate in vivo
measurements.

An iodine 125 based brachytherapy seed, model 6711
from Amersham Health, was modeled in a large liquid water
phantom. The dose deposited in the phantom was recorded at
5 mm intervals up to 5cm from the seed along the transverse
axis and normalized to 1 at 1cm. The particle fluence was
also recorded at 5mm intervals up to 5cm from the seed long
the transverse axis. The number of events in the photopeaks
were counted for each of the spectra and normalized to 1 at
1cm, to simulate the application of spectroscopic dosimetry,
calibrated at a distance of 1cm from the seed. The two depthdose curves were plotted to compare the DOSRZnrc
predicted dose and the spectroscopic dosimetry predicted
dose.

2. Phantom Measurements
1) Depth dose measurements
An iodine 125 based seed was placed inside a gel
phantom. The urethral alarm probe was used to measure the
extrapolated treatment dose at various distances from the
seed along the transverse axis. These doses were plotted in
comparison with TG43 (3) calculated doses.

1. Monte Carlo Simulations
EGSnrc v42) was used for the following Monte Carlo
simulations. The user code DOSRZnrc was used to score
doses in a water phantom whereas the user code FLURZnrc
was used to score particle fluence in a water phantom.

2) Isotropy measurements
An iodine 125 based seed was placed inside a gel
phantom. The urethral probe was placed 1cm from the seed
on the transverse axis of the seed. The probe was rotated 360°
with measurement taken every 30° to measure the azimuth
isotropy of the detector. The probe was then moved parallel
to the seed with measurements taken every 5mm. Each step
of 5mm increased the polar angle of measurement, but also
increased the source to detector distance. The measured dose
vs. expected dose was plotted to investigate the polar
isotropy of the detector.
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III Results

II. Methodology
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1. Monte Carlo Simulations
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The application of spectroscopic dosimetry has been
simulated using FLURZnrc. Fig. 1 shows the comparison of
spectra measured at 0.5cm and 5cm from an iodine 125
based seed. It can be seen from Fig. 1 that the shape of the
spectrum does not change significantly with distance,
although the fluence has greatly decreased. This indicates
that spectroscopic dosimetry may be viable over a large
range of depths (up to 5cm from sources).
a)
Fig. 3 Iodine 125 based seed spectrum as measured by the urethral
alarm probe at a distance of 1cm in free air.

Depth dose curves for an iodine 125 based seed in a gel
phantom as measured by the urethral alarm probe and as
calculated by TG43 are shown in Fig. 4. The urethral alarm
probe has measured the doses to within 5% of the expected
doses.
b)

Fig. 4 Depth dose curve from an Iodine 125 based seed in a gel
phantom as measured by the urethral alarm probe and calculated
using TG433).
Fig.1 Spectra at depths of a) 0.5cm and b) 5cm from an iodine 125
seed.

The azimuthal isotropy of the urethral alarm probe is
represented in Fig. 5. The urethral alarm probe has an
isotropy within 4% of the mean response for 360° about the
detector azimuth.

Fig. 2 Spectroscopic dosimetry predicted dose and DOSRZnrc
predicted dose vs. depth

Fig. 2 shows the depth dose curves for both the
spectroscopic dosimetry predicted doses and calculated
doses, up to 5cm from an iodine 125 based seed.
Spectroscopic dosimetry has predicted the dose to within 2%
of the calculated dose for each point of measurement.
2. Phantom Measurements
The measured spectrum of an iodine 125 based seed in
free air is shown in Fig. 3. Several peaks are well resolved,
indicating the urethral alarm probe is adequate for
performing spectroscopy based dose calculations.

Fig. 5 Azimuthal isotropy of the urethral alarm probe

The polar isotropy of the urethra alarm probe is
represented in Fig. 6. The decrease in dose with an increase
of angle between transverse axis of the seed and direction
from the seed center to the detector is due to the increasing
source to detector distance. The measured doses were within
5% of the calculated doses. The urethral alarm probe exhibits
a polar isotropy to within 5% for angles up to 80° from the
polar axis.
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5% of calculated doses, up to 5cm from sources, and for all
angles of incidence about the detector (for both azimuth and
polar angles).
The urethral alarm probe demonstrates the ability for real
time in vivo dose measurements using spectroscopic
dosimetry. The patented urethral alarm probe will be a very
useful tool in clinical dose verification both during seed
implantation and post implant.
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Fig. 6 Polar isotropy of the urethral alarm probe

IV. Conclusion
The urethral alarm probe has been developed to provide
real time dosimetry for permanent implant prostate
brachytherapy. Monte Carlo calculations have shown
spectroscopic dosimetry to be accurate to within 2% up to
5cm from low energy x-ray sources with distinct emission
spectra. The urethra alarm probe uses spectroscopic
dosimetry to measure low dose rates to an accuracy of within
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